Figure 6.
(a) Loss in cellular viability (%) in MCF-7 breast cell line treated with GO-Ag nanocomposites after 24 h, t-test (* p < 0.05) (b) Linear calibration Plot of GO-Ag vs. cell viability.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.